Loading clinical trials...
Loading clinical trials...
This study proposes to extend the ongoing longitudinal study of health risk behaviors and obtain new data from former adolescents (followed previously from ages 13-22; Times 1-8) now from ages 23 to 28 (Times 9-11). The goal of this study is to examine the contribution of developing neurocognitive markers to substance use in young adulthood by following a well-characterized longitudinal sample.
The main questions it aims to answer is: what are the long-term effects of valuation and control decision-making systems on health risk behaviors? Participants will complete online surveys assessing their substance use behaviors and perform neurocognitive tasks related to risk processing and cognitive control across three time points.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Virginia Tech
Blacksburg, Virginia, United States
Fralin Biomedical Research Institute at VTC
Roanoke, Virginia, United States
Start Date
January 20, 2014
Primary Completion Date
May 31, 2029
Completion Date
May 31, 2029
Last Updated
February 12, 2026
117
ESTIMATED participants
neurocognitive tasks
OTHER
Lead Sponsor
Virginia Polytechnic Institute and State University
NCT04197921
NCT07199335
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions